The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Open accessPublished version of a preprint
Abstract
Cellular senescence suppresses cancer by irreversibly arresting cell proliferation. Senescent cells acquire a proinflammatory senescence-associated secretory phenotype. Many genotoxic chemotherapies target proliferating cells nonspecifically, often with adverse reactions. In accord with prior work, we show that several chemotherapeutic drugs induce senescence of primary murine and human cells. Using a transgenic mouse that permits tracking and eliminating senescent cells, we show that therapy-induced senescent (TIS) cells persist and contribute to local and systemic inflammation. Eliminating TIS cells reduced several short- and long-term effects of the drugs, including bone marrow suppression, cardiac dysfunction, cancer recurrence, and physical activity and strength. Consistent with our findings in mice, the risk of chemotherapy-induced fatigue was significantly greater in humans with increased expression of a senescence marker in T cells prior to chemotherapy. These findings suggest that senescent cells can cause certain chemotherapy side effects, providing a new target to reduce the toxicity of anticancer treatments. Significance: Many genotoxic chemotherapies have debilitating side effects and also induce cellular senescence in normal tissues. The senescent cells remain chronically present where they can promote local and systemic inflammation that causes or exacerbates many side effects of the chemotherapy. Cancer Discov; 7(2); 165–76. ©2016 AACR. This article is highlighted in the In This Issue feature, p. 115
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, through SASP, senescent cells contribute to cancer development162,163 and metastasis164, treatment failure and increased risk of recurrence165.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [165]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The SASP can also explain chemotherapy side effects, such as bone marrow suppression, cardiac dysfunction, blood clotting, or cancer relapse (Demaria et al. 2017; Wiley et al. 2019).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Demaria et al. 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
From Length-independent telomere damage drives post-mitotic cardiomyocyte senescence (2019) · cites this paper as Demaria et al, 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cellular senescence, a central hallmark of aging,13,14 encompasses heterogeneous cellular states triggered by prolonged cell stress resulting in the irreversible arrest of proliferation and permanent changes to cell function in vivo.15,16,17,18,19”
From Uncovering the signatures of aging and senescence in the human dorsolateral prefrontal cortex (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, these detrimental effects were neutralized via genetic or pharmacological clearance of senescent cells 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, high expression of p16 INK4a in circulating Tcells before treatment, presumably a surrogate biomarker of system-wide senescent cell burden, correlates with severe chemotherapy- induced fatigue in patients with breast cancer, suggesting that senescent cells might contribute to the reduced tolerance of older individuals to anticancer therapies 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in mouse models have demonstrated that TIS promotes cardiac dysfunction, inflammation, bone loss, muscle weakness, renal and hepatic failure, haematopoietic insufficiency, and overall frailty 27,111,202 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with cancer, older age (>65 years) is associated with reduced tolerance to anticancer treatment 27 and a greater risk of developing serious AEs 192 , as well as genetic alterations that might lead to reduced sensitivity to treatment; together these features constitute major hurdles for the successful administration of antineoplastic therapies at efficient doses.”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These include increases in local and systemic inflammation and cancer reoccurrence (Demaria et al. 2017).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Demaria et al. 2017
The cited source says what the claim attributes to it.
In the citing paper
“In some cases, these triggers cause fibroblasts to enter a non-proliferative state termed ‘senescence’71, which is distinct from the phenotype of an aged fibroblast.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [71]
The cited source says what the claim attributes to it.
In the citing paper
“For example, DOX-induced systemic senescence was found to promote metastasis in an orthotopic mouse model of breast cancer.”
From Drug repurposing for cancer therapy (2024) · cites this paper as [232]
The cited source says what the claim attributes to it.
In the citing paper
“p16 INK4a expression is considered a common and robust, albeit not necessarily specific, marker of senescence, and its promoter activity and transcriptional activation are extensively exploited as reporters of senescent cells invivo 20,23,27,28 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Alkylating agents 27,95,96 (for example, cisplatin, cyclophosphamide and temozolomide), topoisomerase inhibitors 27,65,91,95 (such as doxorubicin, etoposide and camptothecin) and γ- irradiation 78 , but also microtubule inhibitors 27,97,98 (for example, paclitaxel) and, to a lesser extent, vinca alkaloids 78 (for example, vincristine), have all been identified as senescence inducers in preclinical”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“In tumour- free mice, exposure to the topoisomerase II inhibitor doxorubicin leads to systemically elevated SASP and functional impairment reminiscent of accelerated ageing, which is only explained in part by direct organ toxicity of this chemotherapeutic agent 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Doxorubicin- induced systemic senescence contributed to breast cancer metastasis in an orthotopic mouse model.”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, high expression of p16 INK4a in circulating Tcells before treatment, presumably a surrogate biomarker of system-wide senescent cell burden, correlates with severe chemotherapy- induced fatigue in patients with breast cancer, suggesting that senescent cells might contribute to the reduced tolerance of older individuals to anticancer therapies 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
In the citing paper
“SASP also mediates the harmful effects of senescent cells which accumulate upon chemotherapy treatment as their chronic presence promotes local and systemic inflammation.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“age-related or therapy-induced senescent cells are mainly linked with secretion of inflammatory factors (Baker et al., 2016; Demaria et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“Elimination of therapy-induced senescent cells can prevent cancer recurrence (Demaria et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“Moreover, senescent cells have been implicated in the adverse effects of some chemotherapeutic regimens as well as in the recurrence of specific neoplasms, at least in mice [969].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [969]
In the citing paper
“Therapy-induced senescence plays an important role in determining the outcome of anti-cancer treatment 40, whilst also being responsible for some of its side effects 41.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [41]
In the citing paper
“whilst also contributing to their side effects 41.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [41]
In the citing paper
“Via the SASP, senescent cells contribute to multiple chronic health conditions associated with inflammaging, e.g., atherosclerosis (16), osteoarthritis (17), cancer (18), myeloid skewing in the bone marrow (19), pulmonary fibrosis (20), Alzheimer’s disease and Parkinson’s disease (21–23), and insulin resistance (24).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [18]
In the citing paper
“These persisting senescent cells have been recently tied to multiple chronic diseases other than atherosclerosis, including diabetes mellitus,85 obesity,85 Alzheimer’s disease,86 heart failure,10,87 idiopathic pulmonary fibrosis,88,89 chronic obstructive pulmonary disease,90 chronic kidney disease,91 cancer,92 and osteoarthritis.93”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [92]
In the citing paper
“However, chronic senescence promotes cancer.92”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [92]
In the citing paper
“and paradoxically tumorigenesis (Demaria et al., 2017).”
From Telomeres and cell senescence—size matters not (2017) · cites this paper as Demaria et al., 2017
In the citing paper
“However, senescence may contribute to reduced patient resilience to cancer therapies”
From Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies (2020) · cites this paper as [67]
In the citing paper
“The use of senotherapeutic drugs could potentially be effective in treating a variety of conditions primarily or secondarily mediated by accumulation of senescent cells [6, 33, 67–87].”
From Reducing Senescent Cell Burden in Aging and Disease (2020) · cites this paper as [69]
In the citing paper
“The development of a tumor cell population that escapes from senescence and restarts proliferating may contribute to cancer relapse [342].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [342]
In the citing paper
“Senescent cells have also been postulated to mediate resistance to therapy, while contributing to off-target systemic effects and cancer relapse linked to the treatment with standard anticancer regimens.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [200]
In the citing paper
“In the same model, whole-body clearance of p16 + cells generated by doxorubicin treatment reduces signs of systemic frailty and limits tumor recurrence.200”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [200]
In the citing paper
“Indeed, persistent senescent cells may contribute to detrimental short and long-term side effects of treatment, as well as to metastases and relapse (Demaria et al., 2017).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Demaria et al., 2017
In the citing paper
“the elimination of therapy-induced senescent cells reduced several side-effects of chemotherapy and even cancer recurrence in mice14.”
From A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells (2020) · cites this paper as [14]
In the citing paper
“Furthermore, ablation of senescent cells after chemotherapy can prevent or delay cancer relapse and spread to distal tissues.59”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Moreover, senescent cells accumulate with age in several vertebrate organisms (1), and their elimination can delay the onset of several age-associated disorders in mice (3, 4).”
BackgroundAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“Moreover, senescent cells accumulate with age in several vertebrate organisms (1), and their elimination can delay the onset of several age-associated disorders in mice (3, 4).”
BackgroundInfluentialSelf-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Self-citationDoxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,870
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y. G., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,842
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Self-citationInk4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,000
Wang, H., Yuan, S., Zheng, Q., Zhang, S., Zhang, Q., Ji, S., Wang, W. J., Cao, Y., Guo, Y., Yang, X., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.025 · Cited by 67
Turner, J. E., & Brum, P. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4234765 · Cited by 66
Biomarkers of aging associated with past treatments in breast cancer survivors
Scuric, Z., Carroll, J., Bower, J. E., Ramos-Perlberg, S., Petersen, L., Esquivel, S., Hogan, M., Chapman, A. M., Irwin, M. R., Breen, E. C., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0050-6 · Cited by 66
(2021) · doi:10.1038/s43587-021-00063-1 · Cited by 66
Self-citationRetractedSenolytic targets and new strategies for clearing senescent cells
Ge, M., Hu, L., Ao, H.-S., Zi, M., Kong, Q., & He, Y. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111468 · Cited by 64
Magkouta, S., Veroutis, D., Papaspyropoulos, A., Georgiou, M., Lougiakis, N., Pippa, Ν., Havaki, S., Palaiologou, A., Thanos, D.-F., Kambas, K., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00747-4 · Cited by 64
Induction and Validation of Cellular Senescence in Primary Human Cells
Hernandez‐Segura, A., Brandenburg, S. M., & Demaria, M. (2018) · Journal of Visualized Experiments · doi:10.3791/57782 · Cited by 64
Self-citationThe effect of low- and high-penetration light on localized cancer therapy
Costa, D. F. G., Mendes, L. P., & Torchilin, V. P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.004 · Cited by 64
Induction of Fibroblast Senescence During Mouse Corneal Wound Healing
Wang, X., Qu, M., Li, J., Danielson, P., Yang, L., & Zhou, Q. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-26983 · Cited by 64
Chae, J., Jang, H., Son, C., Park, C., Choi, H., Jin, S., Lee, H., Lee, H., Ryu, J., Kim, N., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00457-4 · Cited by 64
Lee, J. Y., Reyes, N. S., Ravishankar, S., Zhou, M., Krasilnikov, M., Ringler, C., Pohan, G., Wilson, C., Ang, K. K. H., Wolters, P. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci173371 · Cited by 63
Chen, W., Altshuler, R. D., Daschner, P., Salvador-Morales, C., Germain, D. S., Guida, J., Prasanna, P. G. S., & Buchsbaum, J. C. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae163 · Cited by 63
The Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 62
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 62
Targeting mTOR for Anti-Aging and Anti-Cancer Therapy
Fu, W., & Wu, G. (2023) · Molecules · doi:10.3390/molecules28073157 · Cited by 62
An, S., Cho, S., Kang, J., Lee, S., Kim, H.-S., Min, D., Son, E.-D., & Cho, K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920338117 · Cited by 62
Bientinesi, E., Lulli, M., Becatti, M., Ristori, S., Margheri, F., & Monti, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111689 · Cited by 61
Li, S., Wang, A., Wu, Y., He, S., Wen, S., Zhao, M., Zhu, Y., Hu, X., Luo, Y., & Wang, G. (2023) · Immunological Reviews · doi:10.1111/imr.13274 · Cited by 61
Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation
Chang, M., Dong, Y., Xu, H., Cruickshank‐Taylor, A. B., Kozora, J. S., Behpour, B., & Wang, W. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202315425 · Cited by 61
Luo, J., Sun, T., Liu, Z., Liu, Y., Liu, J., Wang, S., Shi, X., & Zhou, H. (2025) · International Journal of Oral Science · doi:10.1038/s41368-025-00380-w · Cited by 61
Senescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 61
Bharti, V., Watkins, R., Kumar, A., Shattuck-Brandt, R. L., Mossing, A., Mittra, A., Shen, C., Tsung, A., Davies, A. E., Hanel, W. G., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111826 · Cited by 60
Owen, J. S., Clayton, A., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom13010067 · Cited by 60
Glycosidase-targeting small molecules for biological and therapeutic applications
Kim, Y., Li, H., Choi, J., Boo, J., Jo, H., Hyun, J. Y., & Shin, I. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00032j · Cited by 60
Gayle, S. S., Sahni, J. M., Webb, B. M., Weber-Bonk, K. L., Shively, M. S., Spina, R., Bar, E. E., Summers, M. K., & Keri, R. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004712 · Cited by 60
Radiotherapy-Induced Senescence and its Effects on Responses to Treatment
Tabasso, A. F. S., Jones, D. J. L., Jones, G. D. D., & Macip, S. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.003 · Cited by 60
Malaquin, N., Vancayseele, A., Gilbert, S., Antenor-Habazac, L., Olivier, M., Brahem, Z. A. A., Fred Saad, C., Delouya, G., & Rodier, F. (2020) · Cells · doi:10.3390/cells9071593 · Cited by 60
Chen, J., Guo, W., Wang, Z., Sun, N., Pan, H., Tan, J., Ouyang, Z., Fu, W., Wang, Y., Hu, W. G., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02670 · Cited by 60
Murray, K. O., Mahoney, S. A., Venkatasubramanian, R., Seals, D. R., & Clayton, Z. S. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112105 · Cited by 59
Yu, S., Chen, M., Xu, L., Mao, E., & Sun, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175490 · Cited by 59
Targeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 59
Hubackova, S., Davidova, E., Boukalova, S., Kovarova, J., Bajzikova, M., Coelho, A., Terp, M. G., Ditzel, H. J., Rohlena, J., & Neuzil, J. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2224-7 · Cited by 58
IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
Homann, L., Rentschler, M., Brenner, E., Böhm, K., Röcken, M., & Wieder, T. (2022) · Cells · doi:10.3390/cells11091514 · Cited by 58
Effects of regular exercise on vascular function with aging: Does sex matter?
Moreau, K. L., Clayton, Z. S., DuBose, L. E., Rosenberry, R., & Seals, D. R. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00392.2023 · Cited by 58
Chiang, A. C. A., Huo, X., Kavelaars, A., & Heijnen, C. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.005 · Cited by 58
Azazmeh, N., Assouline, B., Winter, E., Ruppo, S., Nevo, Y., Maly, A., Meir, K., Witkiewicz, A. K., Cohen, J., Rizou, S. V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16475-3 · Cited by 57
Carpenter, V. J., Saleh, T., Lee, S. M., Murray, G. F., Reed, J. C., Souers, A. J., Faber, A. C., Harada, H., & Gewirtz, D. A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114765 · Cited by 57
Ming, X., Yang, Z. R., Huang, Y., Wang, Z., Zhang, Q., Lu, C., Sun, Y., Chen, Y., Zhang, L., Wu, J., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00750-9 · Cited by 57
Self-citationEl‐Far, A. H., Darwish, N. H. E., & Mousa, S. A. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735419901160 · Cited by 57
Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics
Gao, Y., Wu, T., Tang, X., Wen, J., Zhang, Y., Zhang, J., & Wang, S. (2023) · GeroScience · doi:10.1007/s11357-023-00728-2 · Cited by 56
Hammoud, M. M., Nageeb, A. S., Morsi, M. A., Gomaa, E. A., Elmaaty, A. A., & Al-Karmalawy, A. A. (2022) · New Journal of Chemistry · doi:10.1039/d2nj01646j · Cited by 56
The complex interplay between aging and cancer
Trastus, L. A., & di Fagagna, F. D. (2025) · Nature Aging · doi:10.1038/s43587-025-00827-z · Cited by 56
Senescence and tumor suppression
Hinds, P. W., & Pietruska, J. R. (2017) · F1000Research · doi:10.12688/f1000research.11671.1 · Cited by 56
The Premature Senescence in Breast Cancer Treatment Strategy
Milczarek, M. (2020) · Cancers · doi:10.3390/cancers12071815 · Cited by 56
Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin
Ahmadinejad, F., Bos, T., Hu, B., Britt, E., Koblinski, J. E., Souers, A. J., Leverson, J. D., Faber, A. C., Gewirtz, D. A., & Harada, H. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000354 · Cited by 55
Adem, Y., Galderisi, U., & Alessio, N. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1148761 · Cited by 55
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
Saleh, T., Bloukh, S., Hasan, M., & Shboul, S. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188994 · Cited by 55
HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation
Efimova, E. V., Ricco, N., Labay, E., Mauceri, H. J., Flor, A. C., Ramamurthy, A., Sutton, H. G., Weichselbaum, R. R., & Kron, S. J. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0288 · Cited by 55
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 55
Restored immune cell functions upon clearance of senescence in the irradiated splenic environment
Palacio, L., Goyer, M., Maggiorani, D., Espinosa, A., Villeneuve, N., Bourbonnais, S., Moquin‐Beaudry, G., Le, O., Demaria, M., Davalos, A. R., et al. (2019) · Aging Cell · doi:10.1111/acel.12971 · Cited by 54
Self-citationTherapeutic opportunities for senolysis in cardiovascular disease
Sweeney, M. D., Cook, S. A., & Gil, J. (2022) · FEBS Journal · doi:10.1111/febs.16351 · Cited by 54
Current status of nanoscale drug delivery systems for colorectal cancer liver metastasis
Hong, Y. K., & Rao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108764 · Cited by 54
Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation
Jiang, M., Gu, D.-N., Dai, J., Huang, Q., & Tian, L. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.018 · Cited by 54
The senescence-associated secretory phenotype: Fueling a wound that never heals
Pulido, T., Velarde, M. C., & Alimirah, F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111561 · Cited by 54
Self-citationGuan, L., Crasta, K., & Maier, A. B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101634 · Cited by 54
Csík, B., Nyúl‐Tóth, Á., Gulej, R., Patai, R., Kiss, T., DelFavero, J., Nagaraja, R. Y., Balasubramanian, P., Shanmugarama, S., Ungvari, A., et al. (2025) · Aging Cell · doi:10.1111/acel.70048 · Cited by 53
Hou, J., Yun, Y. J., Xue, J., Jeon, B.-M., & Kim, S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6636 · Cited by 53
Mandelblatt, J. S., Ahles, T. A., Lippman, M. E., Isaacs, C. J., Adams-Campbell, L. L., Saykin, A. J., Cohen, H. J., & Carroll, J. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1160 · Cited by 53
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 53
The struggle of a good friend getting old: cellular senescence in viral responses and therapy
Kohli, J., Veenstra, I., & Demaria, M. (2021) · The EMBO Reports · doi:10.15252/embr.202052243 · Cited by 52
Self-citationSenescent cells in cancer therapy: why and how to remove them
Zhang, J., Zhang, D., & Yu, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.002 · Cited by 52
Al-Warhi, T. I., Al-Karmalawy, A. A., Elmaaty, A. A., Alshubramy, M. A., Abdel‐Motaal, M., Majrashi, T. A., Asem, M., Nabil, A., Eldehna, W. M., & Sharaky, M. M. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2135512 · Cited by 51
Bodywide ecological interventions on cancer
Kroemer, G., McQuade, J. L., Mérad, M., André, F., & Zitvogel, L. (2023) · Nature Medicine · doi:10.1038/s41591-022-02193-4 · Cited by 51
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Henry-Smith, C. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165933 · Cited by 50
“To begin to assess the connection between senescence and DPP4 in hVSMCs, we induced hVSMC senescence using 2 different paradigms: treatment for 7 days with CoCl 2 , a hypoxia mimetic, or with Doxo, a chemo-therapeutic drug that induces DNA damage (20, 21).”
Beltzig, L., Christmann, M., & Kaina, B. (2022) · Cells · doi:10.3390/cells11162588 · Cited by 50
Extracellular citrate and metabolic adaptations of cancer cells
Parkinson, E. K., Adamski, J., Zahn, G., Gaumann, A. K. A., Flores‐Borja, F., Ziegler, C. M., & Mycielska, M. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10007-1 · Cited by 50
Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy
Sami, S. A., Darwish, N. H. E., Barile, A. N. M., & Mousa, S. A. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0694-6 · Cited by 50
Ghorai, A., Mahaddalkar, T., Thorat, R. A., & Dutt, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.023 · Cited by 50
Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells
Yang, D., Tian, X., Ye, Y., Liang, Y., Zhao, J., Wu, T., & Lu, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119196 · Cited by 50
Li, Q., Zhao, Y., Xu, C., Liang, Y., Zhao, Y., He, Q., Li, J., Chen, K., Qiao, H., Liu, N., et al. (2023) · Advanced Science · doi:10.1002/advs.202205668 · Cited by 49
Form follows function: Nuclear morphology as a quantifiable predictor of cellular senescence
Belhadj, J., Surina, S., Hengstschläger, M., & Lomakin, A. J. (2023) · Aging Cell · doi:10.1111/acel.14012 · Cited by 49
Kaina, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237442 · Cited by 49
Carroll, J., Irwin, M. R., Seeman, T. E., Roux, A. V. D., Prather, A. A., Olmstead, R., Epel, E. S., Lin, J., & Redline, S. S. (2019) · SLEEP · doi:10.1093/sleep/zsz089 · Cited by 49
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 49
Accelerated aging in older cancer survivors
Sedrak, M. S., Kirkland, J. L., Tchkonia, T., & Kuchel, G. A. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17461 · Cited by 49
González-Meljem, J. M., & Martínez-Barberá, J. P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03798-7 · Cited by 48
Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients
Bower, J. E., Ganz, P. A., Irwin, M. R., Cole, S. W., Carroll, J., Kuhlman, K. R., Petersen, L., Garet, D., Asher, A., Hurvitz, S. A., et al. (2022) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkac052 · Cited by 48
Wang, L. Y., Xiong, B., Lü, W., Cheng, Y., Zhu, J., Ai, G., Zhang, X., Liu, X., & Cheng, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116474 · Cited by 48
Connecting Cancer to Its Causes Requires Incorporation of Effects on Tissue Microenvironments
DeGregori, J. V. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1207 · Cited by 48
Nagesh, P. K. B., Chowdhury, P., Hatami, E., Kumari, S., Kashyap, V. K., Tripathi, M. K., Wagh, S., Meibohm, B., Chauhan, S. C., Jaggi, M., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b14738 · Cited by 48
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
Rysanek, D., Vašicová, P., Kolla, J. N., Sedlák, D., Anděra, L., Bártek, J., & Hodný, Z. (2022) · Aging · doi:10.18632/aging.204207 · Cited by 48
Mbara, K. C., Devnarain, N., & Owira, P. M. O. (2022) · Pharmaceutical Medicine · doi:10.1007/s40290-022-00444-w · Cited by 47
Montégut, L., Joseph, A., Chen, H., Abdellatif, M., Ruckenstuhl, C., Motiño, O., Lambertucci, F., Anagnostopoulos, G., Lachkar, S., Dichtinger, S., et al. (2022) · Aging Cell · doi:10.1111/acel.13751 · Cited by 47
Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence
Abdelgawad, I. Y., Sadak, K. T., Lone, D. W., Dabour, M. S., Niedernhofer, L. J., & Zordoky, B. N. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107751 · Cited by 47
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics
Hu, D., Yuan, S., Zhong, J., Liu, Z., Wang, Y., Liu, L., Li, J., Wen, F., Liu, J., & Zhang, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107817 · Cited by 47
The Aging–Cancer Cycle: Mechanisms and Opportunities for Intervention
Sedrak, M. S., & Cohen, H. J. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac247 · Cited by 46
Chen, D., Wang, J., Li, Y., Xu, C., Meng, F., Zhang, P., & Liu, L. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1418 · Cited by 46
Priorities in Cardio-Oncology Basic and Translational Science
Salloum, F. N., Tocchetti, C. G., Ameri, P., Ardehali, H., Asnani, A. H., de Boer, R. A., Burridge, P. W., Cabrera, J. Á., de Castro, J., Córdoba, R., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.08.003 · Cited by 46
Zhang, H., Xu, Q., Jiang, Z., Sun, R., Wang, Q., Liu, S., Luan, X., Campisi, J., Kirkland, J. L., Zhang, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202412950 · Cited by 46
Self-citationJeevanandam, J., Tan, K. X., Danquah, M. K., Guo, H., & Turgeson, A. (2019) · Biotechnology Journal · doi:10.1002/biot.201900368 · Cited by 46
Mechanisms of Hydroxyurea‐Induced Cellular Senescence: An Oxidative Stress Connection?
Kapor, S., Čokić, V. P., & Santibanez, J. F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7753857 · Cited by 46
Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types
Limbad, C., Doi, R., McGirr, J., Ciotlos, S., Pérez, K., Clayton, Z. S., Daya, R., Seals, D. R., Campisi, J., & Melov, S. (2022) · iScience · doi:10.1016/j.isci.2022.103848 · Cited by 46
Self-citationSenotherapeutics and Their Molecular Mechanism for Improving Aging
Park, J., & Shin, D. W. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.114 · Cited by 45
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression
Kohli, J. S., Chen, G., Fitsiou, E., Doepner, M., Brandenburg, S. M., Faller, W. J., Ridky, T. W., & Demaria, M. (2022) · Nature Communications · doi:10.1038/s41467-022-35657-9 · Cited by 45
Self-citationLee, D. H., Imran, M., Choi, J. H., Park, Y. J., Kim, Y. H., Min, S., Park, T. J., & Choi, Y. W. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13541 · Cited by 45
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 45
Senescence and Immunoregulation in the Tumor Microenvironment
Ruhland, M. K., & Alspach, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754069 · Cited by 45
Acyl coenzyme A binding protein ( ACBP ): An aging‐ and disease‐relevant “autophagy checkpoint”
Montégut, L., Abdellatif, M., Motiño, O., Madeo, F., Martins, I., Quesada, V., López-Otín, C., & Kroemer, G. (2023) · Aging Cell · doi:10.1111/acel.13910 · Cited by 44
Senescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 44
Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs
Chang, M., Gao, F., Gnawali, G. R., Xu, H., Dong, Y., Meng, X., Li, W., Wang, Z., Lopez, B., Carew, J. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00152 · Cited by 44
Metadata
- Authors
- Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., Alston, S., Academia, E. C., Kilmarx, S., Valdovinos, A., Wang, B., de Bruin, A., Kennedy, B. K., Melov, S., Zhou, D., Sharpless, N. E., Muss, H., & Campisi, J.
- Affiliations
- University Medical Center Groningen (NL)
- 1Buck Institute for Research on Aging, Novato, California.
- University of Arkansas for Medical Sciences (US)
- Buck Institute for Research on Aging (US)
- 4HealthSpan Diagnostics, Research Triangle Park, North Carolina.
- University of North Carolina at Chapel Hill (US)
- 6Department of Pathobiology, University of Utrecht, Utrecht, the Netherlands.
- Corresponding author
- Demaria, Marco
- Campisi, Judith
- ORCID
- Venue
- Cancer Discovery
- Published
- 2017-02-01
- Volume
- 7
- Issue
- 2
- Pages
- 165-176
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC5296251
- OpenAlex
- W2561396377
- Cited by
- 1,338
- References
- 34
- Citations by year
- 2026: 113 · 2025: 153 · 2024: 164 · 2023: 176 · 2022: 198 · 2021: 152 · 2020: 159 · 2019: 105 · 2018: 79 · 2017: 38
- FWCI
- 59.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- UNC Libraries
- Funders
- American-Italian Cancer Foundation
- National Institutes of Health (5r01ag024379-15, AG009909, AG017242, AG041122)
- National Institute on Aging (R56AG009909, R01-AG024379, R37AG009909, P01AG041122, P01AG017242)
- National Cancer Institute (R01CA122023, R01CA166347, R01CA203023, R01CA163896, P30CA016086)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- cellular senescence, therapy-induced senescence, chemotherapy toxicity, senescence-associated secretory phenotype, senolytics, senescent cell elimination, inflammation, tumor recurrence, myelosuppression, cardiotoxicity, chemotherapy-induced fatigue, T cells, genotoxic chemotherapy, transgenic mouse model
- MeSH terms
- Animals, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Mice, Transgenic, Neoplasm Recurrence, Local, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
